Neonatal sepsis is the third leading cause of newborn death worldwide. The antibiotics used to treat it have barely changed in 50 years — and resistance is rising. NeoSep1 is a multi-country adaptive platform trial testing new antibiotic combinations to find safer, more effective treatments.
Our data infrastructure underpins the trial at sites across Africa and Asia, enabling faster recruitment and generating evidence that will directly change treatment guidelines globally.
English
Deutsch
简体中文
العربيّة
